tiprankstipranks
BNB Plus (BNBX)
NASDAQ:BNBX

BNB Plus (BNBX) Price & Analysis

Compare
988 Followers

BNBX Stock Chart & Stats

$1.48
--
Market closed
$1.48
--

Bulls Say, Bears Say

Bulls Say
Low LeverageVery low debt reduces refinancing and solvency risk, giving the company time and optionality to address operational issues without immediate creditor pressure. This structural financial flexibility supports continued operations and strategic choices over the next several months.
Positive Gross MarginA positive gross margin indicates the core product or service covers direct costs, implying viable unit economics. If management can control operating expenses, the firm can leverage these underlying economics to improve profitability as revenue stabilizes or grows.
Board Digital-Asset ExpertiseAdding a seasoned digital-asset executive strengthens governance and strategic execution for BNB treasury and DeFi initiatives. Structural expertise can accelerate product development, partnerships, and credible oversight, improving execution odds over a multi-month horizon.
Bears Say
Sustained Cash BurnMaterial negative operating and free cash flow means the company must rely on external funding or equity issuance to sustain operations. That dependence can cause dilution, constrain strategic investments, and raise survival risk if capital markets tighten over the next several months.
Declining Revenue & LossesSharp revenue decline alongside deep operating losses points to structural demand or execution problems. With margins negative and scale shrinking, achieving operating leverage will be difficult without clear revenue stabilization, impairing long-term profitability prospects.
Nasdaq Delisting RiskA formal Nasdaq notice and ineligibility for automatic cure raise material listing and liquidity risk. Delisting would impair access to institutional capital, reduce trading liquidity, and increase financing costs, materially affecting the company's ability to raise funds and operate over months ahead.

BNB Plus News

BNBX FAQ

What was BNB Plus’s price range in the past 12 months?
BNB Plus lowest stock price was $0.60 and its highest was $30.96 in the past 12 months.
    What is BNB Plus’s market cap?
    BNB Plus’s market cap is $3.76M.
      When is BNB Plus’s upcoming earnings report date?
      BNB Plus’s upcoming earnings report date is May 07, 2026 which is in 40 days.
        How were BNB Plus’s earnings last quarter?
        BNB Plus released its earnings results on Feb 05, 2026. The company reported -$2.083 earnings per share for the quarter, missing the consensus estimate of N/A by -$2.083.
          Is BNB Plus overvalued?
          According to Wall Street analysts BNB Plus’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does BNB Plus pay dividends?
            BNB Plus does not currently pay dividends.
            What is BNB Plus’s EPS estimate?
            BNB Plus’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does BNB Plus have?
            BNB Plus has 5,447,469 shares outstanding.
              What happened to BNB Plus’s price movement after its last earnings report?
              BNB Plus reported an EPS of -$2.083 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -31.746%.
                Which hedge fund is a major shareholder of BNB Plus?
                Currently, no hedge funds are holding shares in BNBX
                What is the TipRanks Smart Score and how is it calculated?
                Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                  Company Description

                  BNB Plus

                  BNB Plus Corp. is a biotechnology company, which engages in the development and commercialization of technologies to produce and detect deoxyribonucleic acid and ribonucleic acid. It operates through the following segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment consists of the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and the development and sale of a proprietary RNAP for use in the production of mRNA therapeutics. The MDx Testing Services segment develops clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The DNA Tagging and Security Products and Services segment is involved in the detection of DNA for industrial supply chains and security services. The company was founded in 1983 and is headquartered in Stony Brook, NY.

                  BNB Plus (BNBX) Earnings & Revenues

                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  ENDRA Life Sciences
                  Intelligent Bio Solutions
                  iSpecimen
                  BioNexus Gene Lab Corp

                  Ownership Overview

                  3.10%0.06%4.45%92.38%
                  4.45% Other Institutional Investors
                  92.38% Public Companies and
                  Individual Investors

                  Options Prices

                  Currently, No data available
                  ---
                  Popular Stocks